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  LEADING EDGE
  Highlights of Current Research
  STUDY SHOWS AN INCREASE IN BABESIOSIS IN LOWER 
HUDSON VALLEY Lyme disease may continue to reign as the most 
prevalent tickborne disease in the Hudson Valley, but now there is a 
growing concern over a dramatic increase in babesiosis, a tick-borne 
infection of erythrocytes. A study led by Julie T. Joseph, M.D., assis-
tant professor of medicine, reveals that the number of Lower Hudson 
Valley residents diagnosed with babesiosis has increased 20-fold, from 
6 to 119 cases per year from 2001 to 2008, compared with an approxi-
mate 1.6-fold increase for the rest of New York, a striking increase since 
babesiosis first emerged in the Hudson Valley in 2001. The authors 
warn that babesiosis has the potential to cause serious illness and 
death, especially in highly immune-compromised patients, and urge 
clinicians to consider babesiosis in persons with fever and hemolytic 
anemia who have been exposed to ticks or received blood products.
 “Babesiosis in Lower Hudson Valley New York, U.S.A.,” Emerging Infectious 
Diseases, May 2011 (Vol. 17, No. 5). Online at http://www.cdc.gov/eid/content/
17/5/843.htm.
  RESEARCH LINKS LONGER LIFE SPAN WITH IMPROVEMENTS 
TO SOCIAL SECURITY College researchers have made the surprising 
discovery that when Social Security benefits are improved, people over 
the age of 65 benefit most, and may even live longer. According to the 
study’s lead author, Peter S. Arno, Ph.D., professor of health policy and 
management, Americans over the age of 65 experienced steep declines 
in the rate of mortality in periods following the introduction of Social 
Security and subsequent improvements to the system. The authors 
found that Social Security keeps nearly 44 percent of older Americans 
out of poverty, helps improve seniors’ living conditions and increases 
their access to medical care, all of which have resulted in longer, health-
ier lives. After controlling for changes in the economy and access to 
medical care, the study reported that, after Social Security was imple-
mented in 1940, death rates among persons 65 and older fell more 
than those of younger age groups. That pattern was also seen in the 
mid-1960s and early 1970s after Social Security benefits were markedly 
improved through legislation and the indexing of benefits to inflation.
  “Social Security and Mortality: The Role of Income Support Policies and 
Population Health in the United States,” Journal of Public Health Policy, May 2011 
(Vol. 32, Issue 2). Online at http://www.ncbi.nlm.nih.gov/pubmed/21326333
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U.S. Army Engages  





Esther L. Sabban, Ph.D., lands a competitive 
military grant to limit and prevent the effects of 
PTSD using an unusual pathway.
S tress is a universal predator. In every society, in any  language and at any age, 
members of the human race can-
not escape the pressure that 
comes with the territory of daily 
life—rich or poor, in sickness and 
in health—until death intervenes. 
But what is one person’s trauma 
can become another’s fascination. 
Why are some individuals resilient 
while others succumb? What are 
the molecular components that 
distinguish between successful 
and unsuccessful adaptation to 
stress? These questions are the 
province of Esther L. Sabban, 
Ph.D., who is a recognized expert 
in exploring the biochemical angle 
of life’s stressors. She has lately 
narrowed her focus to what many 
of her colleagues consider the 
most oppressive variant of all: Post 
Traumatic Stress Disorder (PTSD).
What used to be the final word  
in separating from active duty is 
becoming an ordeal without end 
for a majority of 
service mem-
bers returning 




pitals and medical centers have 
been seeing soldiers burdened by 
traumatic experiences and alarm-
ingly high rates of depression and 
alcohol abuse. While basic science 
researchers like Dr. Sabban look 
for ways to prevent the onset of 
symptoms or keep them from get-
ting worse, the U.S. Department  
of Veterans Affairs, through its 
National Center for PTSD, has 
been providing a growing number 
and variety of programs and tools 
for early intervention—even offer-
ing a free smart phone app, called 
PTSD Coach. It says something 
about the prevalence of the disor-
der, not to mention the sufferers’ 
ongoing need for relief.
A 2010 study in the journal Military 
Medicine examined rates of PTSD 
and the success of the VA pro-
grams among 120 service mem-
bers. The findings for mental health 
problems were considered “quite 
alarming”—6 percent had PTSD, 27 
percent showed dangerous alcohol 
use and another 6 percent carried 
the double burden of PTSD and 
alcohol abuse. A surprising 62 per-
cent reported receiving some kind 
of mental health care since return-
ing home from Iraq or Afghanistan.
The U.S. Army believes stress-
related complaints have become 
so serious a problem for military 
personnel that Congress has man-
dated and the Department of 
Defense has established a number 
of funding opportunities for basic 
and clinical research awards to 
reduce the number of cases, better 
treat the disease and enhance psy-
chological resilience to stress. The 
investment in Sabban’s research 
was based on her innovative proj-
ect to make a significant improve-
ment in the quality of life for service 
personnel. In a global competition, 
she successfully competed against 
hundreds of applicants, and her 
proposal was funded to the tune of 
$1,538,196 over a three-year period.
It wasn’t until 1980 that PTSD was 
added by the American Psychiatric 
Association to the third edition of 
its bible, Diagnostic and Statistical 
Manual of Mental Disorders, com-
monly referred to as DSM-III. 
Although a controversial diagnosis 
By Marjorie Roberts 
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when it was first introduced, the 
disorder has filled an important gap 
in psychiatric theory and practice. 
From a historic perspective, the 
significant change was the stipula-
tion that the etiological agent came 
from outside the person rather than 
an inherent individual weakness. 
There could be no diagnosis of 
PTSD unless the patient had been 
exposed to a traumatic event—one 
that involved actual or threatened 
death or injury, or a threat to the 
physical integrity of the victim that 
caused intense fear, helplessness 
or horror.
One can only imagine how Dr. 
Sabban, who always has a smile 
on her face, would choose such  
a dismal subject to research.  
“The need is there,” she says. 
“Approximately 6.8 percent of the 
U.S. population has PTSD at some 
point in their lives. It is a serious 
psychiatric illness with symptoms 
comprising excessive fear and  
startle, recurring nightmares, and 
problems with social interactions. 
People with PTSD are six times as 
likely as demographically matched 
controls to attempt suicide. It is a 
long and devastating disorder and 
there is a vital need for improved 
medications to treat it.”
Perhaps her attraction was stimu-
lated by the six years she spent  
in Israel, where the stress of possi-
ble annihilation overhangs every 
day. Dr. Sabban earned her B.Sc. 
and M.Sc. degrees from Hebrew 
University in Jerusalem, returning 
home for doctoral studies in bio-
chemistry at New York University 
Medical Center. She remained at 
NYU for a post-doc as an assistant 
research scientist in the depart-
ment of cell biology. By the time 
she left NYU three years later, she 
had become a research assistant 
professor in the departments of 
cell biology and psychiatry.
EARLY hONORS
Dr. Sabban joined New York 
Medical College as an assistant 
professor in 1983 and was the  
first female faculty member in the 
Department of Biochemistry and 
Molecular Biology. In 1986 she was 
promoted to associate professor 
and was made a full professor in 
1991. Her support at the College 
has come mainly from the National 
Institutes of Health. This PTSD grant 
is her first from the Army, though 
she previously received a grant from 
the Office of Naval Research to 
study the molecular mechanisms  
of other types of stress.
Since coming to the College, 
Sabban has been active in medical 
and graduate education, and has 
trained many post-doctoral fellows, 
and masters and Ph.D. students. 
Ten graduates have carried out 
their Ph.D. thesis research in her 
laboratory. She is especially proud 
at having been named recipient of 
the 2000 Dean’s Research Award. 
The honor recognized her national 
and international leadership of 
investigational efforts into the biol-
ogy of the stress response and her 
outstanding contributions toward 
understanding the mechanisms 
that regulate catecholamine bio-
synthetic enzymes. She has pub-
lished more than 140 peer-reviewed 
articles, and participated in many 
review committees, including NIH 
study sections and symposia 
organizing committees. She has 
lectured widely on her research  
in the U.S. and abroad and gave 
the introductory lecture at the 
International Symposium of 
Catecholamines and Other 
Neurotransmitters in Stress.  
She is a recent past president  
of the Catecholamine Society.
A key component of Dr. Sabban’s research requires the use of an elevated plus maze, a tool  
to measure anxiety in rodents. The red lights help ensure a stress-neutral environment.
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Sabban has assembled a strong team that includes 
Lidia Serova, Ph.D, Dr.Sc, a research assistant profes-
sor and longtime collaborator from the Soviet Union 
whom Dr. Sabban invited to the College as a visiting 
scientist in 1995; Andrej Tillinger, Ph.D., a post-doctoral 
fellow with much experience in the biochemistry of 
stress mechanisms, having trained with Sabban’s 
longtime collaborator and prominent stress investiga-
tor, Richard Kvetnansky, Ph.D, Dr.Sc; two Ph.D.  
students, Lishay Alaluf and Regina Nostramo, M.S., 
and Saurabh Malpani, M.S. Maria Gulinello, Ph.D., 
from the Albert Einstein College of Medicine, will par-
ticipate as a consultant for the behavioral aspects of 
the study.
TAkING AIM
Based upon an improved understanding of the 
underlying changes in brain chemistry with PTSD,  
the researchers selected two compounds for nasal 
delivery—Y (NPY) and AGRP (83-132), both alone and 
combined—for their ability to reduce the PTSD reac-
tion and diminish the manifestations of the disorder. 
NPY and AGRP are naturally occurring compounds, 
and increases in their levels in the brain have already 
been linked with resistance to developing PTSD and 
lowering stress-triggered anxiety. AGRP is known to 
inhibit some of the actions of naturally occurring hor-
mones involved with stress. Previous studies by the  
team suggest AGRP (83-132) might be effective in 
treating stress-triggered disorders.
The researchers are using an animal model of PTSD 
called Single Prolonged Stress (a one-time exposure 
to several prolonged stressors). The study will examine 
dose and timing of intranasal delivery of their agents, 
before and after the stress, which the investigators 
predict will have a greater effect when the two com-
pounds are combined. The benefits of this unusual 
method of drug delivery are clear to her. “I am 
pleased the drugs are to be administered in a non-
invasive manner,” Sabban says. “There is evidence 
that they can reach the brain faster and selectively 
because they do not have to pass through the 
blood-brain barrier.”
She continues, “The strength of this work is that we 
are combining investigation of the modulation of PTSD 
symptoms in terms of behavioral features such as anx-
iety, startle and adverse social interactions, which are 
new aspects for us, with molecular and endocrine fea-
tures of stress, which we have much experience with, 
especially the noradrenergic neurons of the brain.
“I’ve been thinking a long time about how to modulate 
stress. I’m hopeful that we will find out if one or a 
combination of the peptides will prevent the develop-
ment of PTSD symptoms, and that the results will pro-
vide new insight into the mechanism of neurochemical 
changes associated with PTSD.” n
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Esther L. Sabban, Ph.D., foreground, leads her team with intelligence—and humor, judging from the smiles. From left are  
Lidia Serova, Ph.D., Dr.Sc., Saurabh Malpani M.S., Andrej Tillinger, Ph.D., Lishay Alaluf, and Regina Nostramo, M.S.
By Cynthia A. Read
ew York Medical College began the year 
enriched by the addition of three new 
researchers with international backgrounds 
and reputations. Appointed in December, they have 
joined the faculty of two departments in the basic sci-
ences. Libor Velisek, M.D., Ph.D., and Jana Veliskova, 
M.D., Ph.D., now settled in their respective labs in the 
Department of Cell Biology and Anatomy, are investi-
gating seizures from intriguingly different points of view. 
In the Department of Microbiology and Immunology, 
Chandra Shekhar Bakshi, D.V.M., Ph.D., has trained his 
sights on tularemia. While the three are studying differ-
ent diseases with diverse methods, together they bring 
fresh ideas and spark new collaborations among their 
colleagues as they bring their expertise into the mix.
SEEkING ThE whY Of SEIzURES
Libor Velisek and Jana Veliskova (then Ortova) met in 
the early 1980s when they were fellow medical stu-
dents in Czechoslovakia. She had initially planned to 
follow in the long line of physicians in her family, but 
he sparked her interest in basic science. The two 
eventually shifted their focus to neurophysiology and 
epilepsy, the specialty of his preceptor. Because of the 
strained political climate of that place and time, more 
research than clinical opportunities were available  
in Prague, where the pair, who were now married, 
wished to remain with their young daughter. By the 
late 1980s, they had already amassed an impressive 
collection of publications on seizures, and in 1991 
they came to the United States and worked at the 
Albert Einstein College of Medicine in post-doc  
positions focusing on developmental epilepsy.
There the two developed their individual research 
expertise while continuing to be prime collaborators, 
eventually obtaining faculty positions in Einstein’s 
neurology and neuroscience departments. The 
Veliseks were drawn to New York Medical College 
because of its collegial atmosphere, as well as an 
opportunity to expand their laboratory. They brought 
with them more than $2 million in grant support, and 
by early spring had assembled a team and begun 
some experiments.
Libor Velisek’s particular specialty is infantile spasms 
(West syndrome), a catastrophic form of epilepsy that 
commonly begins when an infant is four to six months 
old. The syndrome is the result of a compromised 
brain, but the causes are variable and often undeter-
mined. Characterized by clusters of flexion spasms, a 
chaotic EEG between seizures, and usually mental 
retardation, the prognosis is poor.
Velisek describes infantile spasms as “unique, compli-
cated and puzzling.” No other seizures respond to 
Jana Veliskova, M.D., Ph.D.
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treatment with ACTH (adrenocorticotropic hormone) 
and until he developed a valid rat model, there were 
no good animal models for study. To identify what 
causes the brain to seize, and why these seizures do 
respond to ACTH, he is studying the effects of prena-
tal exposure to corticosteroids, which are often pre-
scribed for pregnant women at risk for premature 
delivery. This research is supported by a three-year 
NIH grant “Novel mechanism-based treatments for 
infantile spasms,” on which he is the principal investi-
gator, as well as a grant from the March of Dimes.
Jana Veliskova is using rat models to study how sex 
hormones influence seizures and neuronal excitability. 
It was long believed that estrogens increase suscepti-
bility to seizures, so women with epilepsy were advised 
not to use hormone replacement therapy. But Veliskova 
has discovered that low-dose estrogen is actually neu-
roprotective and has anticonvulsant effects. Besides 
investigating the underlying mechanisms, she is also 
studying how estrogen affects the normal brain, espe-
cially learning and memory. This research is supported 
by a four-year NIH grant. “Neuroprotective strategies in 
seizure-induced damage.”
Drs. Velisek and Veliskova are co-investigators on each 
other’s NIH grants. In addition, he is the principal inves-
tigator and she a co-investigator on a subcontract for 
another NIH grant, “Mechanisms of genetic suscepti-
bility in juvenile myoclonic epilepsy.” This form of epi-
lepsy is inherited, but the exact mode is not clear, and  
they are using a mouse model to build on research by  
Columbia University geneticist David Greenberg, Ph.D.
Joseph D. Etlinger, Ph.D., professor and chairman of the 
Department of Cell Biology and Anatomy, commented, 
“recruiting Libor and Jana was a great opportunity to 
build on our departmental strength in the area of neu-
ral plasticity. Libor’s infantile spasm model and Jana’s 
project on estrogen-dependent seizures both involve 
neurodegeneration and cognitive decline, which should 
lead to exciting collaborations with our faculty studying 
learning and memory, as well as neuronal loss. They 
also bring expertise that will help other investigators at 
the College in monitoring regional brain activity and 
behavior in animals.”
TULAREMIA, A BIOTERRORISM ThREAT
Tularemia, also known as rabbit fever, is a rare but 
often fatal illness caused by the bacterium Francisella 
tularensis. So infectious that inhaling as few as 10 bac-
teria can cause disease, F. tularensis is considered a 
dangerous biothreat agent—in fact, it has been weap-
onized by the United States, Japan and the former 
Soviet Union. Dr. Shekhar Bakshi is studying the 
genetics of F. tularensis, the pathogenic mechanisms 
that cause it to be so virulent, and its interaction with 
the host’s immune system, all with the eventual goal of 
developing a safe and effective vaccine.
Bakshi claims an early and abiding interest in basic 
science, particularly the molecular basis of bacterial 
infections. His initial focus was salmonella, but after 
the attacks of 9/11 and the anthrax scare that fol-
lowed, the NIH began allocating additional funds to 
bioterrorism research. In 2003 Bakshi joined the 
Center for Immunology and Microbial Disease at 
Albany Medical College, which had received a grant  
to study tularemia.
In 2010, Ira Schwartz, Ph.D., chairman of the Depart-
ment of Microbiology and Immunology, sought to 
expand his department’s scope and expertise by hiring 
an additional scientist whose research related broadly 
to the area of microbial pathogenesis and comple-
mented other research activities in the department. 
Bakshi was eager to accept this new position because 
of the department’s strong focus on bacterial diseases. 
It offered a good balance of research and teaching, 
and it would give him the opportunity to work with a 
biosafety level-3 laboratory (BSL-3) with the federally 
mandated biocontainment precautions required for 
Libor Velisek, M.D., Ph.D.
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research with potentially lethal agents such as F. tular-
ensis. (The College’s BSL-3 lab, which has been 
undergoing upgrades, is scheduled to reopen in June.) 
Bakshi’s research is supported by a three-year grant 
from the NIH, for “Immunology and pathogenesis  
of pulmonary tularemia,” as well as a one-year NIH 
bridge grant for “modulation of macrophage function 
by F. tularensis.”
When people are initially infected with the microbe, 
they typically display no signs of sickness or immune 
response. “We now know the bacteria cause active 
immune suppression, which is regulated by genes that 
alter the function of the immune cells,” says Bakshi, 
who has been using both mouse model and in vitro 
studies to better understand the bacteria’s antioxidant 
defenses and virulence. The knockout mutant of 
Francisella, which reduces the virulence of the bacte-
ria, could become the basis for a vaccine to be devel-
oped in much the same way that vaccines for typhoid 
and tuberculosis were cultivated. The mutant might 
also help scientists figure out how to enhance the 
host’s immune response or suppress the activity of  
the infectious form of the bacteria.
“Shekhar Bakshi’s research complements that of 
researchers in the department who are studying how 
hosts mount an innate immune defense to other patho-
gens and so offers a great opportunity for synergy,”  
says Dr. Schwartz of his department’s newest member. 
For his part, Dr. Bakshi says he is looking forward to 
developing new collaborations, and hopes that his 
work on F. tularensis can provide the basis for estab-
lishing a strong biodefense program at the College, a 
vision in which Schwartz has confidence. “Shekhar 
has energetically integrated himself into our depart-
ment, and I expect that he will quickly establish a suc-
cessful, well-funded research program, even within the 
current tight funding climate,” says Dr. Schwartz.
ThE LAST wORD
Francis L. Belloni, Ph.D., dean of the Graduate School 
of Basic Medical Sciences, offered a decidedly enthu-
siastic take on the trio’s arrival at the College. “We are 
thrilled to have these three new researchers join our 
faculty,” he effuses. “Neuroscience and infectious  
diseases are not only two of the College’s areas of 
research excellence, but they are also of great interest 
to prospective graduate students. I have no doubt that 
they will help us in our continuing quest to attract out-
standing young students into our Ph.D. and master’s 
programs. In fact, shortly after their arrival last December, 
even as they were still unpacking, all three of them will-
ingly pitched in to help interview Ph.D. candidates dur-
ing the admission period that was underway, helping 
us select another strong class for next fall. I look for-
ward to working with them in the years to come.” n
Chandra Shekhar Bakshi, D.V.M., Ph.D.
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Dr. Frishman keeps 
William H. Frishman, M.D., is many things: admired teacher, 
academic leader, renowned researcher and history buff who 
still finds time to practice cardiology, write books and cheer 
the Yankees. It’s a balancing act, and he thrives on it.
F rom childhood, William H. Frishman, M.D. shouldered awareness of his family his-
tory of premature coronary dis-
ease—as well as a determination to 
do something about it. While a stu-
dent at the Bronx High School of 
Science, he won the first of many 
national awards he would receive 
throughout his life—this one for 
summer research on hyperthyroid-
ism and the heart at Hunter College 
and Cornell Medical School. “By the 
end of that summer,” he says, “I 
knew I wanted to be a cardiologist.”
Now, Dr. Frishman, the Barbara and 
William Rosenthal Chairman of Med-
icine at New York Medical College, 
Director of Medicine at Westchester 
Medical Center and councilor to 
Alpha Omega Alpha, the national 
honor medical society, has founded 
medical journals and published 
textbooks while presiding over an 
acclaimed department. But he says 
his busy days add up to a well-
rounded life that’s key to his success.
A promising stArt
At the age of 16, young Bill Frishman 
enrolled in Boston University’s six- 
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everything in Balance
year liberal arts/medicine program, 
so by age 22 he was already a 
doctor. His colleagues and mentors  
were luminaries in their field. BU’s 
Robert Wilkens, M.D., won the 
Lasker Prize for advances in the 
treatment of hypertension, and 
Frishman’s two chiefs of medicine 
at Boston City Hospital both 
became editors-in-chief of the  
New England Journal of Medicine. 
His internship advisor at BU was 
Louis Sullivan, M.D., who would 
become Secretary of Health and 
Human Services under President 
George H.W. Bush. To support 
himself in school, Dr. Frishman 
worked at the Joslin Clinic, a major 
institution dedicated to diabetes, 
where many patients also had 
heart disease. On the side, he held 
the job of first-aid attendant at the 
Boston Garden sports arena.
He returned to New York to com-
plete his internal medicine training 
at Montefiore Medical Center and 
Bronx Municipal Hospital Center 
and a cardiology fellowship at 
Cornell University Medical College 
in Manhattan. With the Vietnam War 
at its peak, Frishman enlisted in an 
Army program that allowed him to 
complete his training in a civilian 
hospital. He entered active military 
service as a chief of cardiology at 
U.S. Walson Army Hospital in Fort 
Dix, N.J., and served as front-line 
medical officer in a field unit with 
the 82nd Airborne Division in Fort 
Bragg, N.C. Of his service in the 
military medical corps he says,  
“It is a great privilege and honor to 
care for individuals and their fami-
lies who have made a supreme 
sacrifice to serve our country.” 
Frishman stayed in the reserves 
through Desert Storm in 1990  
and achieved the rank of lieuten-
ant colonel. For his military stint, he 
received the U.S. Army Commen-
dation Medal for Meritorious 
Service. The state of New York 
awarded him the Conspicuous 
Service Cross, its highest honor.
mAjor reseArch
Dr. Frishman entered the field of 
cardiac research during what he 
describes as its “golden era” of 
drug development. “I was involved 
in the development and introduction 
of almost every major cardiovascu-
lar drug used today—beta block-
ers, calcium channel blockers, 
angiotensin converting enzyme 
inhibitors, angiotensin receptor 
blockers and statins.” At the Albert 
Einstein College of Medicine, 
where he rose to become associ-
ate chairman of the Department  
of Medicine and chief of medicine 
at Einstein College Hospital of 
Montefiore Medical Center, Frishman 
was a co-principal investigator in 
the Women’s Health Initiative, a 
massive, historically significant 
clinical trial to study the effects of 
hormone replacement therapy in 
160,000 post-menopausal women. 
He was also co-principal investiga-
tor in the Bronx Longitudinal Aging 
Study, which established risk fac-
tors for heart disease in the elderly.
In his laboratory at New York Med-
ical College, Frishman researched 
thrombosis, regenerative medicine 
and stem cells, the potential future 
of cardiovascular disease treat-
ment. “Our medical school and  
the Departments of Medicine  
and Physiology have been world 
By Melissa f. Pheterson
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leaders in the area of cardiovascular regeneration and stem cell ther-
apy,” he says.
AwArding excellence
In his career, Dr. Frishman has taught more than 6,500 medical students 
and an additional 1,000 medical residents and fellows. “One lesson I 
learned from medical school is to find a mentor who watches over you,” 
he says. “When you falter, a mentor picks you up and pushes you along 
to cross the finish line. I try to be that type of person for my students and 
residents now.”
Frishman has received multiple accolades from New York Medical College 
for his skill as an educator, including 13 consecutive teaching awards from 
the students and residents. His national awards are just as numerous and 
impressive: he received the Association of American Medical Colleges 
(AAMC) Distinguished Teaching Award (“the Nobel Prize of medical educa-
tion”) in 1997 and was a finalist for that organization’s coveted Humanism 
in Medicine Award in 2001. He was elected to Mastership, the highest 
level of membership, by the American College of Physicians-American 
Society of Internal Medicine. He has also received the American Heart 
Association’s Teaching Scholar Award and the Preventative Cardiology 
Academic Award issued by the National Institutes of Health.
But the single honor you’ll hear him talk about most is his involvement with 
Alpha Omega Alpha (AOA), the medical honor society. He is extremely 
proud of his service as a councilor for 33 years—first at Einstein and now 
at the College, making him the only AOA councilor in the nation to serve 
at two institutions. The AOA chapter at New York Medical College has 
been selected many times as the national chapter of the year for its com-
munity service and outreach, he repeatedly points out, adding with undis-
guised pride, “Through AOA, the school and its entire student body have 
gained a national reputation for excellence.”
the writing life
To share his research findings, Frishman has written or collaborated with 
colleagues on more than 1,000 articles, with at least 10 published in the 
New England Journal of Medicine. He has founded two medical journals 
(Clinical Hypertension and Heart Disease, both now published under 
different titles) and penned 12 textbooks on such varied cardiovascular 
topics as stem cell therapy for heart disease, hypertension and alterna-
tive medicine. The third edition of his magnum opus, Cardiovascular 
Pharmacotherapeutics, was published in May and includes contributions 
from many former students, many of whom have become the nation’s 
leading authorities in their own right.
“My purpose for writing books is to synthesize information for other physi-
cians in a clear, concise and focused manner. Their success is my success,” 
says Frishman. He rises early in the morning to write, and credits part of 
his success to the support of his devoted staff (pictured on next page). 
They include administrative secretaries Carol Ruggiero and Charlene 
Benincasa, editorial assistant 
Joanne Cioffi-Pryor, and depart-
ment administrator Maryann Pratt. 
“Our publishing enterprise is really 
a mom-and-pop business,” he 
says. Frishman is also an editor  
of Cardiology in Review (in con-
junction with Harvard Medical 
School) and the American Journal 
of Medicine (the official journal of 
all chairpersons in medicine in 
North America).
For 40 years, Frishman has some-
how found time to maintain an 
active private practice as a general-
ist and cardiologist.
“We have a responsibility not just 
for physical healing, but for psy-
chological and spiritual healing,”  
he says. “After a heart attack, not 
all forms of healing happen at the 
same time. I had a patient who 
was very depressed after his heart 
attack even after his body healed. 
Recently, he came into my office 
and said ‘Dr. Frishman, thank God  
I had the heart attack.’ He learned 
to take more joy in his life, not  
“One lesson I learned 
from medical school is 
to find a mentor who 
watches over you,” he 
says. “When you falter, 
a mentor picks you up 
and pushes you along to 
cross the finish line. I 
try to be that type of 
person for my students 
and residents now.”
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taking anything for granted. I said: 
‘now you’re healed.’
“That’s the joy of patient care,”  
Frishman says. “They’re always 
teaching you something new, reveal-
ing new truths.”
An avid sports fan, the Bronx 
native has attended almost every 
Yankee opening game since 1951. 
He attends Yankees, Knicks and 
Giants games. But, he admits, “my 
major sporting activity is to take 
long walks with my wife Esther, my 
children, grandchildren and dog.” 
Married for 40 years, Frishman 
helped raise “three wonderful  
children, who have settled in the 
area and have blessed us with six 
grandchildren—to date.” Incredibly, 
he manages to visit all his grand-
children daily—just a brief stop on 
his way home from work, but one 
that helps him remember what’s 
most important.
In his downtime before going to 
bed, Frishman enjoys reading about 
history. As a prolific author himself, 
he is drawing on the contacts he’s 
made from the military for the book 
he is now writing about the physi-
cians who have cared for the presi-
dents and vice presidents of the 
United States. “Sometimes the only 
person the president can really 
trust, over and above his cabinet, 
is his personal physician,” he says.
“As pAssionAte As A 
third-yeAr”
And the key to a happy and pro-
ductive life? “Maintaining balance,” 
Frishman says. “I am a better  
clinician because I’m an active 
researcher. I am challenged to be  
a better teacher by my students. I 
am a better researcher because  
I recognize the unsolved needs of 
my patients. I am a better adminis-
trator because I participate in all 
the activities of my faculty as a  
clinician, teacher and researcher.”
A close colleague and former stu-
dent is Stephen J. Peterson, M.D., 
vice chairman and professor of  
medicine. “Dr. Frishman is one of 
the most optimistic people you’ll 
ever meet,” he says. “He has never  
lost his passion for the art and 
science of medicine. He remains 
as passionate as a third-year med-
ical student.”
Ralph A. O’Connell, M.D., provost 
and dean of the School of Medicine, 
who was instrumental in persuad-
ing Frishman to come to the College 
after 25 years at Einstein, called 
him “a Renaissance man, a multi-
faceted individual who is as knowl-
edgeable in history, the arts and 
baseball as he is in medicine. Every-
body does well and everybody 
moves up because [Bill Frishman] 
raises the intellectual curiosity of  
all those around him.”
For Dr. Frishman, though, great-
ness is achieved through the small 
and everyday things. “I look for-
ward to every working day,” he 
says, “with as much enthusiasm 
and zest as ever.” n
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n a bright morning in early spring, 
T.S. Dharmarajan, M.D., guided a visitor 
through the 69-bed geriatrics division on  
the fourth floor of Montefiore Medical Center’s North 
Division. The College-affiliated hospital is located in 
the Bronx, at the former site of Our Lady of Mercy 
Medical Center. As they traversed the corridors, the 
fellowship and residency program director pointed  
out the glare-free lighting fixtures, rounded handrails 
and diamond-in-the-middle floor pattern, which is 
designed to help people with dementia navigate with-
out falling. “They perceive the diamonds as holes, and 
instinctively move toward the railings,” he explained. 
“Many people don’t notice these innocuous-looking 
designs, but they’re very important.”
Seeing his obvious pride in the unit, it’s surprising to 
learn that the man who’s often referred to as “Dr. D” 
didn’t always aspire to being an expert in geriatric 
medicine. The fact is, many medical students and  
new doctors initially shy away from what they perceive 
as a specialty both unglamorous and unrewarding. 
Even when Dharmarajan was asked to start a geriatric 
medicine division—a real opportunity to make his 
mark—he balked. He had been a successful nephrol-
ogist and worried that taking his career in this new 
direction would be a mistake. But many more trained 
geriatricians are needed to combat the nationwide 
shortage, he says, and “no one in the tri-state area 
except Mount Sinai had such a program, nor any idea 
how to develop one.”
So despite his misgivings, Dr. Dharmarajan rose to the 
challenge, and in April 1992, he and nurse manager 
Rosemarie Lifrieri, R.N., M.S.N., M.B.A., kicked off a 
pilot, 17-bed inpatient geriatrics unit. Shortly thereafter, 
he was told to develop a fellowship program to go 
with it. “In July 1993,” he recalls, “one fellow entered 
the program—reluctantly.” It marked the beginning of 
a turnaround, not only in his perception, but also in  
the lackluster reputation of geriatric medicine.
Today, 18 years later, the New York Medical College-
sponsored Geriatric Fellowship Program at Montefiore’s 
North Division, where Dharmarajan is currently vice 
chairman of medicine and associate dean, is thriving. 
With a complement of eight fellows, it is one of the 
largest and most highly acclaimed in the nation. In 2008 
it received five-year approval (the maximum achievable, 
later increased to six) from the Accreditation Council  
for Graduate Medical Education (ACGME), indicating  
a high level of confidence. And just weeks after 
showing his visitor around, he got word that the 
ACGME had approved a permanent increase from  
During rounds, T.S. Dharmarajan, M.D., director of the geriatric fellowship program, pauses to clarify a point with 
geriatric fellows Sowmya Thadisina, M.D., and Waleska Santiago, M.D., and resident Satish Nandyala, M.D.
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8 to 10 fellows. As the program has grown, so has 
Dharmarajan’s estimation of geriatrics shifted dramati-
cally. “Along with marrying my wife,” he declares, “going 
into geriatrics was the best decision I ever made.”
Besides honing their clinical skills, most fellows teach, do 
research, and at the end of the year-long program, take 
the geriatric medicine certification exam conducted by 
the American Board of Internal Medicine. After that, while 
some fellows enter academic medicine, the majority go 
into clinical practice. 
A GRANDMOThER’S LEGACY
When Sowmya Thadisina, M.D., was growing up in 
Hyderabad, India, she helped care for her grandmother, 
who for the last ten years of her life was bedridden with 
undiagnosed neurological problems. At the time, she 
says, “I had the feeling we could have done more for  
her, but we didn’t know what to do.”
Now Dr. Thadisina is learning how to help countless num-
bers of elderly patients to achieve a better quality of life. 
“I’m confident I’m learning the correct way to approach 
patients and their families,” says Thadisina, who began  
a year-long fellowship at Montefiore’s North Division after 
completing her residency in family and preventive medi-
cine at the University of Arkansas in Little Rock.
Along with the other geriatric medicine fellows, Thadisina 
deals with a wide spectrum of patients age 60 and older. 
Their diagnoses run the gamut from constipation and 
hypertension to type 2 diabetes, hip fracture, dementia 
and heart failure. In addition to the hospital, the geriatric 
fellows see patients at local outpatient clinics, nursing 
homes and adult daycare facilities and in patients’ homes.
Dealing with older patients in a variety of settings teaches 
key lessons about caring for this population. One of the 
most important is learning how to distinguish between a 
person’s chronological and physiological age. “Your chron-
ological age is just a number,” explains Dharmarajan. “A 
physically fit 70-year-old can have the functional capacity 
of a much younger person, while those who smoke and 
are sedentary may function as if they were decades older.”
Fellows also must learn the difference between physical 
changes brought about by normal aging and those 
caused by disease. They also need to understand the 
potential dangers of polypharmacy—the prescribing of 
many medications—a critical skill, since up to half of 
American adults aged 65 years or older take five or more 
different medications daily, as well as non-prescription 
remedies and supplements. This puts them at risk of 
adverse reactions from drug interactions. Sometimes 
these adverse reactions may simulate new illnesses, for 
which more drugs are prescribed, further complicating 
the problem. The fact that older patients may have cog-
nitive and memory problems only adds to the chal-
lenges. “No one comes in and says ‘I have Alzheimer’s 
disease,’” notes Dharmarajan, who insists it’s the geriatri-
cian’s responsibility to figure out whether someone has 
the capacity to understand and comply with treatment 
recommendations, and to set up reminders or enlist the 
help of caregivers. 
BEYOND ThE BEDSIDE
Caring for older patients requires more than clinical 
expertise. “You have to have a lot of love to do this kind 
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of work,” says geriatrics fellow Waleska Santiago, M.D., 
who entered the program last September after com-
pleting her residency in Puerto Rico. In addition to 
addressing a patient’s medical issues, geriatricians 
must be able to connect emotionally with patients and 
their families and friends. “To be truly helpful,” she 
explains, “you need to look at the patients’ social lives, 
daily activities and home environments.”
One of Santiago’s most memorable patients was a 
woman who worked as a home health aide. The first 
time she sought care she was seriously ill but was 
afraid to go to the hospital because she didn’t have 
health insurance. After talking with the faculty geriatri-
cian, she agreed to be admitted. While there, she 
saw how her doctor placed her health needs ahead  
of financial considerations and made sure she received 
the inpatient care she needed. Later, it came to light 
that this woman’s daughter had stolen her elderly 
mother’s life’s savings of $5,000, and the only person 
the patient told was Santiago. “It was a defining 
moment for me,” she says, “when I realized how  
much patients trust you, and how sacred the patient-
doctor relationship really is.”
As challenging as geriatrics is for Dr. Santiago, she 
finds it particularly fulfilling, and believes having some 
life experience under her belt is a real plus. “It helps  
a lot in terms of dealing with patients,” she says. “If 
you’ve already been hospitalized a couple of times, 
and faced financial and other problems, you tend to 
be more realistic.”
This means that even when she cannot cure her 
patients, Santiago takes satisfaction in helping them 
cope. “As you get more experience, you realize that 
older people with chronic diseases like heart failure, 
Parkinson’s disease and emphysema can stay active 
and have productive lives if they get the right treat-
ment,” she says. “People with chronic illnesses are  
living longer. They’re not just waiting to die. The pic-
ture is much rosier today, which makes our role even 
more important.”
Her colleague Dr. Thadisina concurs, saying she, too, 
finds fulfillment in playing such an important role in 
her patients’ lives. “The patient’s family looks up to 
you,” she says. “They are looking for someone to 
help them manage their own lives while caring for 
their loved ones. I’m happy to be that person. And I 
like the fact that my involvement doesn’t stop with  
the patient.”
Richard G. McCarrick, M.D., vice dean for graduate 
medical education and affiliations, agrees with the 
importance of recognizing the breadth and depth 
needed to be a good geriatrician. “Geriatrics is one  
of the most challenging fields of medicine, due to  
the broad range of knowledge required. Like pediat-
rics, it deals with all diseases encountered in a par-
ticular age group, so in addition to general internal 
medicine, geriatricians must know a great deal of  
neurology, psychiatry, physical medicine and pain 
medicine,” he says. “The societal need for experts  
in geriatrics is enormous and growing. Because of  
Dr. Dharmarajan, and with the continuing support of 
Montefiore Medical Center, the College is a leader in 
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“A ‘selective’ describes part of the curriculum that’s somewhat elec-
tive, but with a list of options from which students must choose,” 
says Paul M. Wallach, M.D., vice dean for medical education. Last 
July, the School of Medicine began offering some 100 selectives, 
starting in the third year of medical school. The program provides a 
way to rotate students through their major clerkships and then into 
a selective that still relates to the clerkship but does not draw from 
the same resources. Three out of seven clerkships—internal medi-
cine, pediatrics and surgery—have carved out two weeks for selec-
tives that focus on sub-specialties, recent breakthroughs or 
research findings from a related field, with encouraging results.
“We are seeing a national trend among many medical schools 
seeking ways to allow students more choices in the third year,” says 
Gladys M. Ayala, M.D., M.P.H., senior associate dean for student 
affairs and a member of the team that put together the program. 
“The goal is to offer a more diverse range of educational offerings 
that will allow some exploration before a student’s career path is 
set in stone. We’ve been careful to arrange selectives in a manner 
that complements the weekly clerkship themes and core curricu-
lum. This allows students a broader and deeper educational experi-
ence—one that goes beyond the core curriculum without distracting 
from its most important tenets.”
Jennifer L. Koestler, M.D., associate dean for medical education, is 
another member of the think tank that helped restructure the cur-
riculum, fitting more students into a complicated matrix of clinical 
Curriculum
How students explore career 
interests, begin thinking like 
scientists, and learn how to 
answer questions as well as  
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How do you maxi-mize the teaching of medical stu-
dents at the patient’s 
bedside without creating 
a bottleneck? How do 
you keep the curriculum 
fresh, relevant and 
responsive to the chang-
ing dynamics of medi-
cine? And how do you 
grant medical students 
sufficient opportunity to 
explore career interests 
before they begin inter-
viewing for their resi-
dency? Creative thinkers 
in the School of Medicine 
have found an answer in 
a new and innovative 
curriculum program 
known as “selectives.”
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training opportunities that is 
becoming tighter every year. For 
Koestler and her fellow forward-
thinking educators, the selectives 
option is a clear win for students. 
“Part of the role of a selective is to 
permit students to try out some-
thing they might not otherwise learn 
about, and also pursue interests 
they are passionate about,” she 
says. One selective in surgery, for 
example, is devoted to hyperbaric 
medicine to review new wound care 
therapies. Selectives in pediatrics 
include adolescent care, genetics 
and metabolism, neurology and 
developmental psychology. In their 
fourth year, students take two more 
selectives—one in emergency 
medicine, another of the students’ 
choice—for a total of five. The small 
class size (fewer than ten, often just 
one or two enrollees) allows profes-
sors and students to become better 
acquainted and speak their minds.
A TOUCh Of ThEATRE
Among the most popular selec-
tives—though you might not guess 
it by the name—is Translational 
Research, designed in response to 
new medical education guidelines 
that reflect “a growing interest in 
making sure medical school gradu-
ates understand medical research,” 
Wallach explains. “That kind of 
bench-to-bedside process is how 
life-saving therapies are produced, 
but it’s something few doctors 
could articulate. We wanted to 
ensure our graduates had a firm 
grasp on it.”
Victor A. Fried, Ph.D., professor of  
cell biology and anatomy, conducts 
the selective in a room of archived 
books at the Health Sciences Library. 
“We’re surrounded by ancient books 
of medical knowledge,” he says. 
“It’s great theatre—an almost mys-
tical experience that hopefully gets 
them plugged in.”
Once he captures their attention, he 
gets to the meat of the class: how 
to critically evaluate research. “So 
many people judge a study by the 
journals that publish it, or whether  
it was covered in The New York 
Times,” he says. “Patients can 
Google studies on cancer and  
diabetes and assume the findings 
apply to them.” To Fried, the word 
“translational” has two different 
meanings. “First, what are the path-
ways by which basic knowledge is 
translated into practical outcomes 
for clinicians? Second, how do you 
translate new findings into lay lan-
guage for patients who’ve been 
reading about them in the press  
or online?” Fried says he deploys 
“no specific technical material,  
just logic and common sense” to 
sharpen his students’ analytic skills. 
“Patients will come in and say, ‘Doc, 
I hear that if I go on a low-calorie 
diet, I’m going to live longer.’ When 
we hear that, we look carefully at 
the paper to see if the data can  
justify the conclusions.”
“I spend five years teaching critical 
thinking to graduate students,”  
Fried allows. “In two weeks, I don’t 
expect medical students to become 
experts, but I do want them to stop, 
think and ask the right questions.” 
From the medical literature, each 
student evaluates a study that may 
be awaiting clinical trials. One stu-
dent reviewed a paper that sought 
a link between the flu vaccine and 
autism and schizophrenia in mice, 
Curriculum
“We’re surrounded by  
ancient books of medical 
knowledge. It’s great 
theatre—an almost 
mystical experience that 
hopefully gets them 
plugged in.”
—Victor A. Fried, Ph.D.
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probing for design flaws and qualifiers. “The big ques-
tions arose: What were the controls? How well did the 
study measure DNA and RNA, or show viral load? Are 
the numbers statistically significant? What was the 
variance? How well can we extrapolate to humans?” 
Fried reflects that students may find his selective “an 
interesting break from their regular routine—where 
they’re mostly answering, not asking, questions.”
STUDENTS AS TEAChERS
On the flip side, selectives can also impress students’ 
abilities upon professors. “It is enriching to spend two 
weeks in a row with the same student,” says Ronald 
Jacobson, M.D., who directs the selective in pediatric 
neurology. The clinical associate professor of pediat-
rics and chief of pediatric neurology at Maria Fareri 
Children’s Hospital says, “What captured my interest 
and opened my heart was how much I enjoyed learn-
ing from my students. They bring a high degree of  
personal insight to our interactions.”
Jacobson’s students join him in seeing patients at  
his faculty practice in Sleepy Hollow, N.Y. “Outpatient 
issues in neurology tend to be much more diverse 
than what students would encounter in hospital rota-
tions,” he says. “[In the selective] we often have an 
hour-plus to get to know the patient and explore these 
issues in depth.” He makes sure the students get a 
thorough grounding in the basics, but he also reaches 
beyond medical matters to discuss ethical concerns, 
and will often factor in the parents’ perspective for a 
rich assessment of each patient’s condition.
“What does [the condition] mean for the child, his life, 
his family? How do parents feel about sending a child 
with seizures back to school? What if a child has 
debilitating headaches and can’t leave the house? 
We’re able to go way beyond textbook descriptions,” 
he says. Each student selects a patient’s case—often 
a highly specific condition that spans multiple fields—
and develops a PowerPoint presentation. “The stu-
dents become my teachers,” Dr. Jacobson says, 
praising both their research skills and their computer 
savvy. “These PowerPoints are professional enough to 
use as formal teaching tools. I’m assembling an entire 
library of them,” says Jacobson.
Julie Grimes, Class of 2012, enrolled in pediatric neu-
rology last summer to gauge her interest in the field. 
Observing Dr. Jacobson treat a broad spectrum of 
neurological conditions was “enjoyable, educational 
and inspiring,” she says. “He was always so focused 
and attentive. Since then, I have made a concerted 
effort to incorporate those valuable conversational 
Paul M. Wallach, M.D., Gladys M. Ayala, M.D., M.P.H., and Jennifer L. Koestler, M.D., comprise the close-knit team that has been 
strategizing new approaches to the medical school curriculum.
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skills into my own interactions with 
patients.” In selecting a topic to pre-
sent, Grimes chose that of an 8-year-
old boy who had complained of 
fainting during baseball practice. “His 
father noted that, unlike the other boys, 
his son did not sweat,” she says—
suggesting a disorder of central ther-
moregulation. “When I mentioned 
this, Dr. Jacobson smiled and pulled 
a textbook off his shelf, opened to a 
dog-eared page, and handed it to 
me.” It was a chapter on pediatric 
disorders of the hypothalamus and 
pituitary gland that he wrote in 1999. 
“At that very early stage in my third 
year,” she says, “the experience of 
thoroughly researching a specific 
topic relating to patient care was a 
transformative one.” For her, the 
selective “has been truly one of the 
highlights of my time at New York 
Medical College.”
While the selectives program was 
conceived, approved and deployed  
in record time, necessitated by the 
closing of Saint Vincent’s Hospital, 
Manhattan and the attendant reshuf-
fling of clerkships and residency  
programs, the benefits to students, 
faculty and the College have more 
than made up for the time crunch. 
“We started out thinking we had a 
good idea that might help to offset 
the need for more clerkship sites,” 
says Dr. Wallach. “Once the selective 
programs were in place, however, we 
realized we had a way to bring our 
medical school curriculum to a whole 
new level. It’s been a quantum leap in 
what we can offer our students.” n
“Outpatient issues in neurology tend to be 
much more diverse than what students would 
encounter in hospital rotations. [In the selective] 
we often have an hour-plus to get to know the 
patient and explore these issues in depth.”
—Ronald Jacobson, M.D. 
Ronald Jacobson, M.D., knows that even a neurological exam can be fun.  
He demonstrates his method to medical student Julie Grimes and his patient,  
six-year-old Cyrus Arjomand.
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Almost all cancers are directly related to mistakes in our 
DNA genetic code, pro-
ducing mutations that 
lead to unregulated prolif-
eration. The faithful main-
tenance of the structure 
and order of the bases 
along the DNA strands is 
of utmost importance to 
cellular function and dis-
ease prevention. As the 
cells in the human body divide, each DNA strand must 
be accurately copied. Yet each cell is constantly sub-
jected to damage to its DNA—from environmental 
chemicals, including some that are similar to those 
used in cancer chemotherapy, and from normal cellu-
lar metabolism. A number of mechanisms exist to rec-
tify the situation: elaborate signaling pathways detect 
DNA damage, and then activate and orchestrate a 
range of cellular responses that include DNA repair.
In our laboratory we are studying DNA polymerase. 
This protein, one of the central enzymes involved in 
DNA replication, is made up of four subunits that  
add DNA bases to the growing strand with incredible 
accuracy and speed during replication, and are also 
involved in DNA repair. Our laboratory has discov-
ered that when cells are exposed to specific agents 
that damage the DNA, P12, the smallest subunit of 
DNA polymerase, is degraded, thereby generating a 
3-subunit enzyme. Our laboratory has demonstrated 
that this 3-subunit enzyme displays a decreased ten-
dency to insert the incorrect DNA base onto the grow-
ing DNA strand, indicating that p12 degradation in  
response to DNA damage could be a mechanism to 
prevent incorporation of mutations into the DNA in the 
face of damage.
We have determined that p12 degradation is depen-
dent on at least one major protein, ATR, which is cen-
tral to the cellular response to DNA damage. We are 
currently trying to determine the role of the related 
protein, ATM, in p12 degradation, and we will further 
determine which proteins are involved in the mecha-
nisms that lead to p12 degradation. We also hope to 
determine whether different mechanisms are utilized 
for the degradation of p12 in different stages of the 
cellular life cycle. An in-depth analysis of the response 
of DNA polymerase to DNA damage will contribute to 
the growing knowledge of how human cells respond 
to and repair DNA damage. Such knowledge could 
potentially lead to new molecular targets for the gener-
ation of chemotherapeutic drugs against cancer.
➤ ChRISTINE LEROY, originally from West Caldwell, 
N.J., is an M.D./Ph.D. candidate in the laboratory of 
Marietta Lee, Ph.D., professor of biochemistry and 
molecular biology. Ms. LeRoy joined the M.D. pro-
gram in 2006, and entered the M.D./Ph.D. program in 
2008. She has embraced the opportunity to perform 
research to improve understanding of the molecular 
mechanisms that guard the cell against mutation and 
cancer pathogenesis. She recently received the Ruth 
L. Kirschstein Predoctoral M.D./Ph.D. fellowship from 
the National Institutes of Health. Ms. LeRoy ultimately 
intends to pursue a career in academic medicine work-
ing as a physician-scientist, allowing her to be involved 
in patient care as well as the advancement of knowl-
edge that will lead to new treatments against cancer.
Polymerase Delta: DNa rePlicatioN aND rePair JoiN Forces
By Christine LeRoy
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By Sini Skariah, M.S. ’05
Where the research focus is on Toxoplasma, a parasitic protozoa that 
causes toxoplasmosis in humans, 
the question is not an idle one. 
Approximately 25 percent of adults 
in the U.S. carry the infection, 
commonly acquired by ingesting 
food or water contaminated by  
the cyst forms of the parasite. In 
infected individuals, the parasite 
forms latent cysts that are found 
primarily in the brain and muscle 
tissues and can persist for years. 
Although the infection is generally 
asymptomatic in healthy individu-
als, it poses serious health risks in 
people with depressed immunity, 
such as transplant recipients and 
AIDS and cancer patients. It can 
also be passed to a fetus across 
the placenta. Treatment is available 
for controlling early stages of the 
infection but no medications are 
available that can target the cysts 
once they have formed.
The parasite requires a host cell to 
grow and replicate as it lacks nec-
essary components to sustain life 
outside the host cell. Macrophages 
are specialized immune cells that 
generate a response to infections. 
The body activates these macro-
phages to kill infectious agents. 
Toxoplasma has evolved to be 
capable of infecting and replicating 
within macrophages themselves, 
even using them for dissemination 
to the brain and muscle tissues 
where it forms cysts. In fact, 
Toxoplasma is able to protect itself 
within an infected cell by modifying 
it to its liking.
Our goal is to identify mechanisms 
by which this pathogen survives 
within and even modifies macro-
phages that are genetically pro-
grammed to destroy it. Identification 
of such mechanisms should pro-
vide researchers with targets which, 
if blocked, can help contain the 
parasite and block formation of its 
cyst stage.
Using a genetics approach, we 
have identified two novel parasite 
genes that enable Toxoplasma to 
survive within macrophages. These 
gene-encoded proteins play a role 
in countering the nitrosative stress 
generated within activated macro-
phages. Such immune evasion 
mechanisms allow Toxoplasma to 
survive within innate immune cells 
and use them for dissemination. 
Ongoing work in the lab is aimed 
at identifying other genes and 
mechanisms by which Toxoplasma 
replicates in macrophages. 
➤ SINI SkARIAh, M.S. ’05, born, 
raised and educated in New Delhi, 
India, has been working toward her 
Ph.D. in the laboratory of Dana G. 
Mordue, Ph.D., assistant professor 
of microbiology and immunology. 
During her studies toward first a 
bachelors and then a master’s 
degree in microbiology at the 
University of Delhi, she became 
interested in doing research that 
would integrate infectious diseases 
and immunology. Her ongoing 
work with Dr. Mordue has helped 
her achieve that goal, and she now 
hopes to increase understanding of 
how pathogens can establish 
chronic infections and find novel 
ways to target them for eradica-
tion. Ms. Skariah, who graduated 
with distinction in May, is this year’s 
winner of the Graduate Faculty 
Council award to a Ph.D. student 
showing noteworthy academic 
achievement and creativity. n
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A native Texan, Justin Segraves, Class of 2014, began his college career in engineering, but quickly realized it wasn’t for him. When his grandmother became ill and required a colostomy, the time he 
spent in and out of the hospital with her, observing the level of care she 
required, motivated him to try a career in nursing.
“I knew that ultimately what I wanted to do was interact with and care for 
patients. At the time it seemed that nursing was the best fit for me. I hon-
estly believed it for a very long time,” he says.
Working on a gastrointestinal surgery floor at MD Anderson Cancer Center 
in Houston during training, and again after graduating with a B.S. from the 
University of Texas at Houston School of Nursing, Segraves was drawn to 
the specialty of wound, ostomy and continence care. Working with patients 
who were especially vulnerable, he says, “was not only technically challeng-
ing and rewarding, but it also gave me the opportunity to work with the 
underlying emotions of the patients themselves.” Recalling his grandmoth-
er’s experience made him keenly aware of the powerful role a nurse can 




school wasn’t  
part of their 
plans. Sometimes 
plans change. 
So every Friday he leaves campus and drives three hours to their home in 
the Philadelphia suburbs, staying until early Monday morning to squeeze 
in as much family time as possible. Overall, Segraves says he is enjoying 
the medical school experience and feels a sense of accomplishment in 
returning to school and doing well.
“My previous experience with patients has given me some perspective,” he 
says. “There really is so much you need to know to fully care for patients. 
Seemingly irrelevant information you encounter as a medical student often 
turns out to be quite relevant in the clinical setting. I think my prior nursing 
experience gave me a good understanding of that.”
BACk TO SChOOL
While the idea of medical school 
didn’t initially appeal to him during 
his college years, he was thirsty 
for knowledge and eager to have 
more say in how patients should 
be treated. With the encourage-
ment of his wife, Yun Shin Chun, 
M.D., a surgical oncologist whom 
he met while working at MD 
Anderson, Segraves began apply-
ing to medical schools. Soon after, 
his wife, who was pregnant with 
the couple’s first child, accepted a 
position as an attending surgeon 
at Fox Chase Cancer Center, and 
they moved to Philadelphia. For a 
year, he was a stay-at-home dad 
for their son, Joshua, while waiting 
to hear if he had been accepted to 
medical school.
“The whole experience has been 
humbling in many regards. To  
go from having a good career to 
becoming a full-time student again 
was scary,” he says. “There were 
many obstacles we needed to over-
come as a family, too. My mother-
in-law came from South Korea to 
stay with us and help out with our 
son for six months. I’m so grateful 
to her and I don’t know what we 
would have done without her.”
Now 28, Segraves just completed 
his first year at New York Medical 
College, a school he chose as a 
near-perfect fit for multiple reasons. 
Besides being impressed by the 
caliber of the curriculum and clini-
cal experiences, the College just 
happens to be his wife’s alma 
mater (she is a 1999 alumna). Even 
better, its location within a reason-
able distance of home enables him 
to commute to Philadelphia to be 
with his family on weekends.
“i stayed really focused and treated my studies like a job. 
i would study until 4 or 5… and if i had more work to do i 
would do it after [the kids] had gone to bed.”
—Reuben Reich, Class of 2011
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fAMILY MAN TO  
MEDICINE MAN
Growing up with a mother and 
father who were both physicians, 
Reuben Reich, Class of 2011, always 
believed he wasn’t the type to go 
into medicine.
“To be honest, my plan was to do 
anything but go to medical school. 
My parents gave me plenty of their 
time, but they both worked a lot 
and I grew up in an environment in 
which they were very busy. Couple 
that with not having much liking 
for blood,” he jokes, “and I didn’t 
believe I would ever want to go 
into medicine.”
While attending college in San 
Diego, Reich studied business, 
“which seemed like a reasonable 
choice at the time.” After graduat-
ing with a B.A. in business admin-
istration in 1999, Reich worked at 
several positions in the business 
sector. That included one with a 
start-up Internet technology com-
pany that offered just about every-
thing he was seeking in a job. But, 
as he now says, “I didn’t feel like  
I was doing anything meaningful, 
and that bothered me.”
It was then that Reich began to 
soul search. After taking a number 
of personality and career inventory 
tests, he found out something  
his father already knew: his ideal 
career path wasn’t business, it  
was medicine.
Through a post baccalaureate pre-
medical program, he completed 
the science courses he needed to 
apply to medical school. Then he 
headed back to his home state of 
Colorado, where his wife Carly was  
pursuing a master’s degree, and 
took a job as a clinical research 
associate in cutaneous oncology at 
the University of Colorado Health 
Sciences Center. He and Carly 
bought a house and had a son, 
Liam. When Reich was accepted at 
NYMC, he deferred enrollment for a 
year to give himself and the family 
time to sell their house and prepare 
to move across the country with 
their infant. The Reiches settled 
into student housing on the Valhalla 
campus in the summer of 2007.
Landing a research fellowship in 
the Department of Cell Biology and 
Anatomy before his second year 
only made more demands on his 
time. Then last year he won a dis-
tinguished Physicians of Tomorrow 
scholarship from the American 
Medical Association, which required 
high academic standing and a 
demonstrated commitment to 
community involvement. But 
despite his hectic schedule, he 
managed to juggle studies and 
community obligations with family 
responsibilities, which included  
the birth of the couple’s second 
child, Brigitta.
“I stayed really focused and treated 
my studies like a job. I would study 
until 4 or 5 in the afternoon and 
then come home and have dinner 
and play with the kiddos and help 
with baths and bedtime,” he says. 
“If I had more work to do I would 
do it after they had gone to bed.”
At the age of 34, Reich can look 
back and say, “I have no regrets. 
It’s been a longer, possibly more 
arduous route for me but it’s all 
been worth it.”
A CALL TO DERMATOLOGY
Reich’s experiences outside of 
medical school may have shaped 
his future. While at the University of 
Colorado, he worked with patients 
with late-stage melanoma and 
cutaneous t-cell lymphoma, and 
realized how much he enjoyed the 
specialty of dermatology. Although 
residencies in the specialty are 
extremely competitive, Reich was 
determined to apply for one, doing 
several away rotations in dermatol-
ogy to gain experience. Although 
he had hoped to take his family 
back to the West Coast, that has 
been put on hold for now. This 
past March he learned that he had 
landed a prestigious match in der-
matology at Brown University in 
Rhode Island, where he will begin 
his residency after a preliminary 
year at Greenwich Hospital in 
Connecticut.
As always, Reich’s family will be by 
his side for the next phase of his 
journey. None of it would have 
been possible without Carly, whom 
he describes as “the rock of our 
family, extremely supportive and 
adventurous.” They hope their chil-
dren, now five and two, will look 
back on these years as “a grand 
adventure.”
In preparing to leave New York, 
where the family spent many happy 
hours at the Bronx Zoo and traips-
ing the walking trails of the Hudson 
River, they look forward to the 
quintessential New England life  
that awaits.
“It’s going to be a great experience,” 
Reich says. “We’re all very excited 
about it.” n
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GREGoRY T. ShERR, M.D. ’04, M.P.h. ’04
“It’s not brain surgery!” This healthy put-down not only 
works to bring someone down a peg, it also confers a  
certain confidence that anyone who practices neurosur-
gery is in a class by himself. And so it is that Gregory T. 
Sherr, M.D. ’04, M.P.H. ’04, is designated a neurosurgeon-
intensivist based upon the arduous training that took more 
than a decade to pull off. That’s what it entails when you 
change occupations and leave other talents behind to dog-
gedly pursue an ever-evolving dream. He has finally fulfilled 
the promises he made to his mentors, friends and family—
that no matter what it took, he would succeed in becoming 
a trauma neurosurgeon. Dr. Sherr really did it “his way” by 
pursuing fellowship skills that usually are gained after a 
residency is completed. As a result, in his first year of 
practice he is certified to perform complex neuro-trauma 
surgery and is a qualified, fellowship-trained intensivist.
Greg Sherr got his M.D. degree from the School of 
Medicine and his M.P.H. in medical informatics from the 
School of Public Health together in May of 2004. As a 
College employee and an early admissions applicant, he 
navigated the admission process handily. There were some 
who wondered, did he have an ulterior motive when he 
accepted the position as New York Medical College’s first 
webmaster in 1997? With a slight shrug, he never answers 
the question. He brought so much experience and author-
ity to the job from his prior job working on the Columbia 
University website that he was able to help elevate web 
services for the entire Valhalla campus. Sherr built the 
College website from a handful of pages to many thou-
sands, until departments all around the university were 
vying to get their pages done. But as hectic as the job was 
(he regularly sent emails at 3 a.m.), and how routinely he 
exceeded expectations, it never diminished the fire in his 
belly for medical school.
GRAvITATES TO NEUROLOGY
“I was looking for a strong medical program at the same 
time I was working in information technology, programming 
in multiple languages,” he says. “While building the home 
page for the Department of Neurology, I developed a 
strong bond with the chairman [Joseph Masdeu, M.D.], 
who along with Steve Marks [M.D., professor of neurology] 
mentored me on my path to becoming a neurological sur-
geon.” What turned out to be the critical mass during his 
first year of medical school was his leadership of Student 
Physician Awareness Day (SPAD), and his meeting with the 
keynote speaker, the late Fred Epstein, M.D. ’63.
“I had the great honor of befriending and working with 
Fred, a giant in the field of neurosurgery. It was his chal-
lenge and inspiration that helped guide me toward a career 
that has been both grueling and rewarding in ways I never 
would have expected,” says Sherr of the pediatric surgeon 
who became famous for saving the lives of children with 
brain stem tumors that had been considered inoperable.
As he gathered a trusted core at the College to help and 
advise him, Sherr began to disengage from the protective 
envelope of Columbia, where he had completed his under-
graduate general studies and post baccalaureate premedi-
cal programs.
A neurosurgeon-intensivist treats patients  
in the ICU after saving their lives in the ER.  
Talk about multi-tasking.
By Marjorie Roberts
Gregory T. Sherr, M.D. ’04, M.P.H. ’04 came to the College as its first 
webmaster. Now he’s the first webmaster-turned-neurosurgeon. 
(Photo by Paul Middlestaedt)
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NOD TO MINNESOTA
Sherr matched for residency at the University of Minnesota 
in Minneapolis and his wife Laura was admitted to the 
Ph.D. program in psychology. Like so many graduates 
before them, they stayed on there after he completed his 
residency. At the age of 41, Dr. Sherr seemed destined for 
an orderly private practice that would leave him time to 
revel with the couple’s three-year-old son Zach, whom he 
modestly calls “very smart and adorable.” But the easy 
way has never been Sherr’s route. He is already managing 
a new venture that could actually put him on call around 
the clock, day after day. This is the Sherr method of multi-
tasking—defined as two achievements for the price of one.
In addition to the modest house he bought on a resident’s 
salary in Minneapolis, the Sherrs have a rented apartment 
in St. Cloud to mitigate a commute that even northern 
Minnesota can’t escape. “I’ve been growing the neuro-
trauma program at St. Cloud Hospital, which we hope will 
become a Level 1 center. St. Cloud is located near a recre-
ational area where people hike, camp, cross country ski 
and snowmobile—which also makes it prone to disasters. 
Patients used to be flown down to the Twin Cities for care. 
Now if a neurosurgeon is on call, I am the first doctor they 
call,” says Dr. Sherr. “Typically there is spine reconstruction 
involved and sometimes a head injury. I am fortunate to  
be able to control the recovery of the patient from start  
to finish. I can handle everything urgent that needs to be 
done—putting in central lines, tracheotomy, gastrostomy 
lines, ventilator management—things that neurosurgeons 
typically don’t do. I do need to call on orthopedic and gen-
eral surgeons when injuries involve the abdomen and the 
long bones. I call them the icing on the cake.”
GRATIfICATION UNBOwED
Dr. Sherr has joined a small neurosurgical practice that 
services a large regional medical center where he can do it 
all. “I never went into it for the money,” he says. “It’s a gift 
to be able to do what I do…I’ve even had my 15 minutes of 
fame already.” He is referring to news video from Fox 9 
Twin Cities News in January that revealed the life-saving 
surgery he performed on a 16-year-old girl. That she sur-
vived the high speed rollover crash on her way to school 
on a snowy day was a miracle in itself, but Dr. Sherr’s per-
formance is good for two miracles. “It was quite scary…I 
was literally pulling bones away from the deep anterior spi-
nal cord to relieve pressure,” he told the interviewer. In the 
operating room he removed the fractured vertebrae and 
replaced it with an expandable titanium cage graft and 
then secured it in place with a plate and screw construct 
to allow bony fusion.
Born to help people, and to do it without an attitude,  
Dr. Sherr smiles as he recounts similarities between his 
story and that of William T. Couldwell, M.D., Ph.D, another 
College mentor who was chairman of the Department of 
Neurosurgery from 1997 to 2001: “His very first job was in 
Fargo, North Dakota, only 170 miles from where I am now. 
He came to the College and then moved on to a bigger 
challenge at the University of Utah. You know,” he muses, 
“my wife loved living in Westchester County. Now, if only 
the College can make me chairman of neurosurgery…” n
First-year medical students Greg Sherr and Chetan Deshpande 
appeared pleased after their White Coat Ceremony in the fall  
of 2000.
“If a neurosurgeon is on call, 
I am the first doctor they 
call. Typically there is spine 
reconstruction involved  
and sometimes a head injury.  
I am fortunate to be able to 
control the recovery of the 
patient from start to finish.”
—Gregory T. Sherr, M.D. ’04, M.P.H. ’04
the00s
Mohana Namle, M.S. ’10, has a 
full-time position as an associate 
researcher in the Department of 
Clinical Immunology at Mount Sinai 
School of Medicine.
Ali Imran, M.P.H. ’06, reports he 
is the head of the Department of 
Community Medicine at Al-Tibri 
Medical College and Hospital, Isra 
University in Karachi, Pakistan.
Joshua D. Quick, M.D. ’06, who 
was married last year, is finishing up 
an active duty tour as a U.S. Naval 
Flight Surgeon with Marine Aircraft 
Group 29 at Marine Corps Air Station 
New River in Jacksonville, N.C. He 
will begin his residency training in 
anesthesiology at Massachusetts 
General Hospital in July.
Tim McClung, M.P.H. ’01, serves 
as an adjunct lecturer in health care 
quality for the masters in health care 
administration program at Western 
Connecticut State University in 
Danbury, Conn.
the90s
Haru Okuda, M.D. ’99, was named 
U.S. Department of Veterans Affairs’ 
National Medical Director for the 
Veterans Health Administration 
Simulation Learning Education and 
Research Network (SimLEARN) 
Program.
Randy Goldberg, M.D. ’97, was 
elected a fellow of the American 
College of Physicians.
Maria Scunziano-Singh, M.D. ’93, 
resides and practices in the Tampa 
Bay area with her husband. They are 
employed in a busy practice with 
multiple specialties and primary care 
physicians. She focuses on comple-
mentary and alternative medicine 
and they reach out to the community 
through educational seminars, sup-
port groups and organic gardening. 
“We have four beautiful children and 
our first is a young teen who has a 
medical career already planned!” 
she writes.
Philip Goodwin, M.D. ’92, reports 
the birth of his second daughter, 
Riley Elaine, who joins Mia Emily.
Jeffrey Marable, M.D. ’90, is the 
medical director of ob/gyn at 
Columbus Neighborhood Health 
Center in Columbus, Ohio.
the80s
Van L. Wagner, M.D. ’89, and his 
Heart of America Bariatrics practice, 
achieved a milestone by performing 
the 300th single incision weight loss 
surgery in St. Louis. Dr. Wagner 
developed the technique known as 
PeriUmbilical Laparoscopic Surgery.
Steven J. Litman, M.D., ’87, was 
named to Castle Connolly’s top  
doctors for pain management. He is 
an interventional pain management 
specialist with expertise in treating 
patients with acute and chronic pain 
from his office in Bay Shore, N.Y.
Milestones
ALUMNI  AChIE V EMENTS
AT A PRESTIGIoUS  
MEDICAL SChooL, hE 
WEARS ThREE hATS, ALL 
FoR ThE LoVE oF SCIENCE.
Brian Lamon, Ph.D. ’07 
By Andrea kott, M.P.h.
His doctorate from New York Medical College had barely 
cooled before Brian Lamon, Ph.D. ’07, landed not one  
but three jobs at Weill Cornell Medical College of Cornell 
University. Within just a few years of graduating, the  
young scientist was balancing duties as assistant dean  
of research development, director of medical student 
research and assistant professor in the department of 
pathology and laboratory medicine. Lamon won’t say 
which one he likes best, partly because he resists being 
pigeon-holed, but mostly because he thrives on the 
interplay of all three.
Finding work in today’s market is tough, especially for a 
recent doctoral graduate. Yet even before graduating, 
Lamon received an offer to do postdoctoral research in 
the lab of David Hajjar, Ph.D., the Frank H.T. Rhodes 
Distinguished Professor of Cardiovascular Biology and 
Genetics at Weill Cornell Medical College. Hajjar and 
Lamon first met in 2006 when Lamon, then president  
of the Graduate Student Association and chair of the 
Graduate Student Research Forum, invited Hajjar to be a 
guest speaker. The two hit it off immediately, recognizing 
their shared passion for the biochemistry of atherosclero-
sis, and it wasn’t hard for Hajjar to recognize the young 
investigator’s exceptional talent. Lamon had already  
co-published an impressive array of scholarly papers  
and earned several awards.
Since he officially began his postdoctoral research in 
Hajjar’s lab, Lamon has enjoyed a meteoric rise at Weill 
Cornell. In 2009, he was appointed assistant professor 
and a year later, director of medical student research and 
assistant dean of research development. It is a full load, 
one that gives him the variety that he missed as a solo 
laboratory scientist. “I love teaching and interacting with 
others. That’s something you don’t get to do as a straight 
scientist,” he says.
He is also a family man. He met his wife, Agnes McNamara, 
at New York Medical College when she was a medical 
student. Agnes, who was about to graduate with her M.D. 
as we went to press, will soon start her residency in anes-
thesiology at St. Luke’s Roosevelt Hospital in Manhattan. 
Oh, and they are expecting their first child in June.
In this section of Chironian, we publish the Class Notes sent 
by you, our readers. News items should be brief, timely—
and legible! Submit Class Notes online at www.nymc.edu/
AlumniAndDevelopment/Secure/address.asp, or mail to 
Alumni Relations, New York Medical College, 40 Sunshine 
Cottage Road, Valhalla, NY 10595. You can also follow us 
on Twitter—our user name is @NYMC_tweets.
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Sanford Silverman, M.D. ’86, was 
named one of the 70 best pain man-
agement physicians in America by 
Becker’s ACS Review. Dr. Silverman 
is director of Comprehensive Pain 
Medicine in Pompano Beach, Fla.
Deborah Fried, M.D. ’83, of 
Woodbridge, Conn., writes “Help. 
They’re trying to convince me I am 
54 years old and my kids are 18 and 
20 and in college. It just keeps get-
ting weirder!”
Joan Liman, M.D. ’83, M.P.H. ’93, 
reports the birth of her second 
grandchild Marissa Erin Gottlieb in 
January. She joins older brother 
Ryan Levi who is now 2½ years old.
Harriett E. Dickenson, M.D. ’82, 
is still with the New York City 
Transit Authority.
Malcolm Z. Roth, M.D. ’82, 
recently completed his term as 
president of the New York Society  
of Plastic Surgeons and is now  
president-elect of the American 
Society of Plastic Surgeons.
Brian Solow, M.D. ’82, had a 
great visit with former classmates 
Joseph Lobl, M.D. ’82, Beth Karon, 
M.D. ’82, and Barry Karon, M.D. 
’82, while in Rochester, Minn., on 
business.
Clifford S. Deutschman, M.D. ’80, 
is president-elect of the Society of 
Critical Care Medicine, the leading 
international organization dedicated 
to ensuring excellence and consis-
tency in the care of critically ill and 
injured patients. Dr. Deutschman is 
professor of anesthesiology and criti-
cal care, attending physician on the 
surgical critical care service at the 
Hospital of the University of Pennsyl-
vania and an internationally known 
NIH-funded sepsis investigator.
the70s
Richard H. Becker, M.D. ’79, is 
practicing cardiology at Hudson 
Valley Hospital Center and serves as 
medical director of its hospitalists 
group. He is also a councilman on 
the town board of Cortlandt, N.Y.
John K. Conant Jr., M.D. ’79, of 
Cheshire, Conn., closed his solo 
practice last year and is now doing 
locum tenens work part time. He 
looks forward to doing things he 
hasn’t been able to do for the last 25 
years and has no second thoughts or 
doubts about his decision to have a 
personal life again.
Steven M. Fruchtman, M.D. ’77, is 
vice president clinical development 
of Spectrum Pharmaceuticals in 
Irvine, Calif.
Edward Jacobson, M.D. ’75A, 
practices gynecology in Greenwich, 
Conn., specializing in cosmetic and 
restorative vaginal surgery and natu-
ral hormone replacement therapy. 
He also has secondary offices in 
Beverly Hills and London.
Dan K. Morhaim, M.D. ’75, deputy 
majority leader in the Maryland 
House of Delegates, is a recipient of 
the American Medical Association 
2011 Dr. Nathan Davis Award for 
Outstanding Government Service in 
the category Outstanding Member of 
a State Legislature. The award rec-
ognizes outstanding public service in 
the advancement of public health.
John T. Stinson, M.D. ’75, of 
Rockville, Md., was named one of 
the 100 Best Spine Surgeons and 
Specialists in America by Becker’s 
Hospital Review.
the60s
Lewis M. Feder, M.D. ’68, was 
voted one of the top 100 cosmetic 
surgeons of the world at the 
International Academy of Cosmetic 
Surgery in Cartagena, Columbia in 
2009.
Johanna A. Pallotta, M.D. ’62, 
associate professor of medicine at 
Harvard Medical School and a senior 
physician at Beth Israel Deaconess 
Medical Center in Boston, is the 
recipient of the 2010 Outstanding 
Clinical Endocrinologist Award by  
the American Association of Clinical 
Endocrinologists.
Edwin S. Stempler, M.D. ’61, spe-
cializes in non-operative orthopedics 
and osteoporosis diagnosis and 
treatment. His wife, Norma, helps 
him in his office. They are living in 
the same condo in Rancho Mirage, 
Calif., since they moved from New 
York three years ago.
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After earning his bachelor’s degree in biology and French 
at Lafayette College in Easton, Pa., Lamon entered the 
College’s pharmacology master’s program; 18 months 
later he began pursuing his doctorate. He dedicated his 
graduate research—conducted under the tutelage of 
Alberto Nasjletti, M.D., professor of pharmacology—to 
studying hypertension, specifically the role that inflamma-
tion plays in the development of atherosclerosis, a subject 
for which the Department of Pharmacology is renowned.
As assistant dean of research development, Lamon is a 
pivotal player in the acquisition of nongovernmental fund-
ing for faculty research. As director of medical student 
research, he helps students identify the research opportu-
nities they need to complete their advanced biomedical 
sciences requirement. “I run the experience component—
getting them into the right lab, setting them up with the 
right mentor and finding funding,” Lamon says.
Students need Lamon’s approval before they can start  
a research project, which culminates in a final report. “It 
has to be a specific, scholarly, hypothesis-driven research 
component to complement their education,” he explains. 
“They can’t just shadow a physician.” This year he has 
worked with some 50 students, helping them prepare 
grant proposals, secure letters of recommendation and 
write their reports.
Lamon is ambitious yet content, since his responsibilities, 
while varied, allow him to use his science to help others. 
“People tend to develop tunnel vision when they’re doing 
the same things over and over,” he says. “I have my 
hands in all the different aspects of the latest research.  
No two days are very much alike, which is nice.” n
Brian Lamon, Ph.D. ’07, who studied and researched hypertension as 
a graduate student here, now teaches, mentors and guides young 
scientists and medical students at Weill Cornell Medical College.
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CoMBINING ThE SCIENCE 
AND ART oF VoICE
Chandler Thompson, D.M.A., M.S. ’05, 
CCC-SLP
By Andrea kott, M.P.h.
Without knowing what drives Chandler Thompson, M.S. 
’05, you might consider her, well…a groupie. After all,  
she counts among her clients Levon Helm, the two-time 
Grammy-winner and former drummer for The Band, as 
well as a host of other famous actors and musicians whose 
identities she is not at liberty to reveal. But Thompson isn’t 
after backstage passes or autographs. She simply wants 
to combine the science of caring for the voice with the art 
of using it well.
As a speech-language pathologist, Thompson helps peo-
ple overcome the effects of lisp, stroke, traumatic brain 
injury, stuttering, and cleft lip and palate on speech. She 
also happens to be a classically trained singer who spe-
cializes in working with professionals who need their voice 
to work and are therefore prone to vocal overuse. This 
includes teachers, cantors, actors and, yes, rock stars.
You may wonder how Thompson—who once eked out a 
living by singing at weddings, Friday night synagogue serv-
ices and in church choirs—rediscovered herself as a clini-
cal speech pathologist and vocal coach to rock ’n rollers. 
First, she accepted the improbability of ever making a liv-
ing by singing. “It’s very hard—unless you live in New York 
or Los Angeles or work for a cruise line,” says the witty  
IN MEMoRIAM
Alumni
Wendy Ann White-Ryan, M.D. ’93, 
died November 30, 2010. She  
was 45.
Karen F.T. Bladykas, M.D. ’87, 
(Fifth Pathway), died July 16, 2010.
Eugene A. Seville, M.D. ’81, died 
on November 2, 2010. He was 55.
David J. Arluk, M.D. ’75, Ph.D., 
died August 18, 2009.
John J. Conroy III, M.D. ’70, died 
April 3, 2011. He was 66.
Fred D. Sheftell, M.D. ’66, died 
April 11, 2011. He was 70.
Martin I. Bertman, M.D. ’65, died 
December 9, 2010. He was 71.
William M. Taylor, M.D. ’64, died 
June 30, 2010. He was 72.
Michael G. Kinsella, M.D. ’62, died 
October 13, 2009. He was 72.
Frederick E. Siefert, M.D. ’60, 
died January 12, 2011. He was 80.
Charles D. McCullough, M.D. ’58, 
died December 20, 2010. He was 81.
Donald A. Peck, M.D. ’56, died 
March 26, 2011. He was 81.
F. William Bora, M.D. ’54, died 
February 23, 2011.
Robert Hirsch, M.D. ’54, died 
March 21, 2009. He was 83.
Robert K. Houlihan, M.D. ’54, died 
November 10, 2010. He was 83.
Gerald H. Levin, M.D. ’54, died 
May 27, 2010. He was 83.
Alfred Sporn, M.D. ’54, died 
August 5, 2010. He was 83.
A.C. True, M.D. ’54, died 
November 28, 2010. He was 81.
William F. Westlin Jr., M.D. ’54, 
died February 28, 2011. He was 83.
William P. Mimnagh, M.D. ’53, 
died March 3, 2010.
Joseph M. O’Connor, M.D. ’53, 
died April 4, 2011. He was 87.
Anna M. Seebode, M.D. ’53, died 
December 16, 2010.
Marvin A. Linder, M.D. ’50, died 
August 13, 2010. He was 82.
Robert W. Niehaus, M.D. ’50, died 
April 24, 2011. He was 85.
Michael H. Scoppetuolo, M.D. ’50, 
died February 12, 2011.
Margot Ammann-Durrer, M.D. ’49, 
died December 28, 2010. She  
was 88.
Donald L. Duerk, M.D. ’48, died 
April 3, 2011. He was 87.
Donald Gribetz, M.D. ’47, died April 
10, 2010. He was 84.
Joseph T. Pedulla, M.D. ’47, died 
April 5, 2011. He was 88.
Raymond E. Schipke, M.D. ’46, 
died November 26, 2010. He was 88.
Ezra J. Epstein, M.D. ’45, died 
November 23, 2009. He was 88.
Harry C. Sayre, M.D. ’45, died 
November 26, 2010. He was 89.
Paul H. Stillman, M.D. ’45, died 
October 24, 2008. He was 87.
Robert P. Brezing, M.D. ’44, died 
December 31, 2010. He was 90.
Eleanor T. DePaoli, M.D. ’44, died 
March 24, 2011. She was 91.
Michael R. Ettenson, M.D. ’44, 
died February 16, 2011. He was 93.
George G. Green, M.D. ’43, died 
January 2, 2011. He was 92.
Tobias M. Rubin, M.D. ’43, died 
June 11, 2010. He was 93.
William Tenenblatt, M.D. ’43, died 
March 18, 2010. He was 91.
Theodore R. Struhl, M.D. ’42, died 
April 23, 2011. He was 94.
Matthew S. Mickiewicz, M.D. ’41, 
died March 27, 2011. He was 95.
G.R. D’Amato, M.D. ’39, died 
November 29, 2009. He was 95.
Regina G. Gabler Greenberg, M.D. 
’37, died July 22, 2009. She was 96.
Nicholas Knox, M.D. ’37, died 
November 18, 2009. He was 97.
Faculty
Alvin Montreo Brown, M.D., clinical 
assistant professor of rehabilitation 
medicine, died September 26, 2010.
Chandler Thompson, D.M.A., M.S. ’05, CCC-SLP, has successfully 
shaped a healthcare career around her encyclopedic knowledge of 
music and voice.
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Alfred M. Freedman, M.D., professor and 
chairman emeritus of psychiatry, died April 
17, 2011, at the age of 94. Dr. Freedman, 
a gifted psychiatrist and social reformer, 
served as chair of the Department of 
Psychiatry and Behavioral Sciences from 
1960 until his retirement in 1988. During 
that time he built the department into an 
important teaching institution with a large 
residency program. He also significantly 
expanded the psychiatric services offered 
at Metropolitan Hospital, where he was 
director of psychiatry. Dr. Freedman was 
an international leader in his field, serving 
as president of the American Psychiatric 
Association, the American Psychopathological 
Association and the American College of 
Neuropsychopharmacology, and founding 
editor of the Comprehensive Textbook of 
Psychiatry. He received the College’s first 
Terence Cardinal Cooke Award and the 
APA’s Human Rights Award.
Edwin D. Kilbourne, M.D., professor 
emeritus of microbiology and immunology, 
died February 21, 2011 at the age of 90. A 
leading authority on influenza, Dr. Kilbourne 
was a member of the College faculty from 
1992 until his retirement in 2002. He 
established the College laboratory that 
supplied the recombinant strains used in 
preparing the annual influenza vaccine 
used worldwide, and it continues today.  
Dr. Kilbourne donated a catalog of nearly 
200 influenza virus reassortants and 
mutants to the National Institutes of 
Health to enable scientists free access  
to the library of viral artifacts, named the 
Kilbourne/New York Medical College Archive.
Bernard N. Nathanson, M.D., clinical 
associate professor of obstetrics and 
gynecology, died February 21, 2011 at  
the age of 84.
Ronald N. Ollstein, M.D., clinical profes-
sor of surgery, died December 30, 2010 at 
the age of 76.
Sidney Weinstein, M.D., research profes-
sor of psychiatry and behavioral sciences, 
died November 8, 2010.
Sidney P. Zimmerman, M.D., clinical 
assistant professor of medicine, died 
February 25, 2011.
Trustees
Robert C. Macauley died December 26, 
2010 at the age of 87. He served on the 
board from 1990 to 1994.
Katherine Sullivan Meehan died February 
16, 2011 at the age of 92. She served on 
the board from 1978 to 1995.
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Mississippi native. Next, she decided to shape a career around her ency-
clopedic knowledge of music and voice.
With a bachelor’s degree in music from Louisiana State University, a mas-
ter’s from Mississippi College and a doctorate from Michigan State 
University, Thompson taught singing and other related voice courses for 
15 years. She taught at Mississippi College, Middle Tennessee State 
University and Vanderbilt University and continued to sing on the side, 
which she still does. But preparing talented singers for a jobless market 
frustrated her. Besides, by the time she was in her late forties, she felt 
herself aging out of the field. “If you’re famous, like Placido Domingo, the 
students want to take classes from you,” Thompson says. “But if they see 
two or three younger people on the faculty, that’s who they want.” After 
her husband survived a near-fatal health crisis in 2002, she realized she 
needed a new, full-time career—with health benefits—and enrolled in the 
College’s master’s program in speech-language pathology.
The rigorous course work tapped into much of Thompson’s expertise. 
Still, the two-year program, which entailed dissecting a cadaver (“I didn’t 
know if I could do that!”), was tough. “In some ways, it was harder than 
earning my doctorate,” she says. “I could have stopped being a singing 
teacher and gone into real estate. It would have been about the same 
learning curve.”
She did neither. Instead, she became a sought-after clinician for facilities 
like the Westchester Institute for Human Development, the Horace Mann 
School and the Grabscheid Voice Center at Mount Sinai Hospital. She has 
also become a highly regarded voice teacher, referred by physicians and 
other singers she has met since earning her M.S. (SLP) degree in 2005.
Although coaching rock musicians and other celebrities is fun, it isn’t easy, 
especially when she must persuade them that vocal repair takes time. “It’s 
usually a confluence of events that causes vocal impairment—a hormone 
shift, a new baby, lack of sleep, reflux, a head cold and vocal misuse. 
Something in their anatomy has gotten out of balance. They can’t fix that 
by themselves but they think they should be able to,” Thompson says.
It can also entail some unusual tasks, like helping Levon Helm, a laryn-
geal cancer survivor, warm up his voice for a 4 a.m. taping of “Imus in  
the Morning,” or tagging along to band rehearsals to see what might be 
aggravating a singer’s vocal problems. Living on the road, performing in 
loud, dust-filled clubs and not getting enough sleep are all ingredients for 
poor vocal health, says Thompson, who analyzes what her clients eat, 
how much water they drink, the medications they take and how much 
sleep they get. “I have one band that sleeps in a school bus,” she says of 
an up-and-coming group, one of many on her client list. She has also 
learned a technique to help rockers—many of whom have no vocal train-
ing—scream in a “technically healthy way.”
“My goal is not to change their style,” she says. “When a patient comes to 
me, and they’re making it and have two CDs out…the goal becomes, how 
do we do this better?” Finding the answer to questions like this is what 
drives Thompson. “I like combining the science and the art,” she says. n
Photos This Page
   alumni reunion: The Class of 1986.
   Commencement: Jennifer L. Sevush, M.D. ’11, 
and her father Steven Sevush, M.D. ’76.
   alumni reunion: Karl P. Adler, M.D., chief 
executive officer, Eileen M. Dieck, M.D. ’86, 
alumni association president, and Ralph A. 
O’Connell, M.D., provost and dean of the 
School of Medicine.
  
   alumni reunion: David E. Asprinio, M.D., 
professor and chairman of the Department of 
Orthopedic Surgery, and 2011 Medal of Honor 
recipient Rudolph F. Taddonio Jr., M.D. ’71.
   Founder’s dinner: Alumni Association presi-
dents Joseph F. Dursi, M.D. ’59, Saverio S. 
Bentivegna, M.D. ’50, Louis E. Fierro, M.D. 
’60, Eileen M. Dieck, M.D. ’86 (current presi-
dent), Christopher F. X. Riegler, M.D. ’88, and 
Michael A. Antonelle, M.D. ’62.
   alumni reunion Luncheon: Henry Saphier, 
M.D. ’61, Robert D. Green, M.D. ’61, and  
Ms. Jacqueline Reilly.
  
   alumni reunion: The Class of 1961.
   
  
  Photos Next Page
   nYMC/touro Barbecue: Alan Kadish, M.D., 
president, Dr. Mark Hasten, chairman of the 
Board of Trustees, and William H. Frishman, 
M.D., the Barbara and William Rosenthal Chair 
of the Department of Medicine.
\    Commencement: Richard J. Vasak, M.D. ’11, 
and his mother Lisa T. Vasak, M.D. ’92.
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COLLEGE EVENTS & ALUMNI REUNIONS 
  
   nYMC/touro Barbecue: Alan Kadish, M.D., 
president, Rob Astorino, Westchester County 
Executive, Dr. Mark Hasten, chairman of the 
Board of Trustees, and Karl P. Adler, M.D.,  
chief executive officer.
   Commencement: Darrell G. Kirch, M.D., presi-
dent and CEO of the Association of American 
Medical Colleges, gave the Commencement 
address.
  
   Commencement: Ralph A. O’Connell, M.D., 
Karl P. Adler, M.D., Alan Kadish, M.D., and 
deans Francis L. Belloni, M.D., and Robert W. 
Amler, M.D. 
  
   Founder’s dinner: Surrounded by his family, 
Saverio S. Bentivegna, M.D. ’50, center, received 
the 2011 William Cullen Bryant Award.
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President
Henry I. Saphier, M.D. ’61
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Charles W. Episalla, M.D. ’88
Vice President
John R. Addrizzo, M.D. ’64
Treasurer
Joseph L. Giamelli, M.D. ’02
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Archivist
Elected Governors
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Louis E. Fierro, M.D. ’60
Rita F. Girolamo, M.D. ’51*
Cyrille R. Halkin, M.D. ’45*
Henry P. Leis Jr., M.D. ’41*
David T. Mininberg, M.D. ’61
E. Edward Napp, M.D. ’33*
Christopher F. X. Riegler, M.D. ’88
Seymour Schlussel, M.D. ’51*
Lawrence B. Slobody, M.D. ’36*
Martin L. Stone, M.D. ’44
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It’s official: New York Medical College 
is now part of the Touro College and 
University System, creating one of 
the largest affiliations of medical 
and health education and biological 
studies programs under one institu-
tional banner. 
An announcement was made on May 25, 2011, by 
leaders of both institutions at a press conference 
held at Bryant Park in New York City, named for 
the College’s most well-known founder, 18th cen-
tury poet and editor William Cullen Bryant. Touro 
President and Chief Executive Officer Alan Kadish, 
M.D., said, “Touro’s goal is to help assure that the 
illustrious legacy, heritage, and accomplishments  
of New York Medical College are secured and that 
its momentum continues. We look forward to the 
synergy that will result from fusing two significant 
institutions and creating one of the broadest arrays 
of health science education programs available 
anywhere.”
Karl P. Adler, M.D., NYMC’s chief executive officer, 
said, “This affiliation will enhance the training of 
tomorrow’s medical and health care leaders, and 
offer them exposure to the benefits of other 
professional study programs in law, pharmacy, 
allied health and the humanities. This kind of inte-
gration exemplifies how medicine and healthcare 
will be taught and practiced in the future. Joining 
our two institutions, and harnessing their respective 
strengths, is how we plan to address the future 
needs of healthcare delivery.”
Later in the day Touro hosted a celebratory barbe-
cue on the Valhalla campus, attended by some 
1,200 members of the College community and 
guests from Touro. Westchester County Executive 
Rob Astorino was on hand to welcome Touro 
College to the county and to praise the union that 
will enhance both institutions. 
The Touro College and University System educates 
approximately 5,300 students in medicine, health, 
and the biological sciences. Chartered in 1970 and 
headquartered in New York City, Touro is America’s 
largest not-for-profit, independent insti tution of 
higher and professional education under Jewish 
auspices, now with approximately 19,000 students 
studying at 32 locations in New York, Cali fornia, 
Nevada, and other states, as well as campuses 
abroad. In addition to a law school, graduate schools 
in several other disciplines, and an array of under-
graduate schools, Touro operates three colleges of 





and offers programs around the country that train 
students to work in a variety of allied health profes-
sions such as physical therapy, occupational ther-
apy, speech-language pathology, nursing, physician 
assistantship, public health, and other areas.
As part of the transaction, Dr. Kadish has been 
named president of New York Medical College, 
while Dr. Adler continues as CEO. A new board of 
directors, which includes four members of the prior 
NYMC board and is led by Dr. Mark Hasten, long-
serving chairman of the board of trustees of the 
Touro College and University System, was officially 
seated on May 25. 
Leaders of both institutions have said that they 
expect a seamless transition, with very few 
changes in the operation of the school. “The 
changeover has been remarkably smooth thus far, 
and we expect that pattern to continue as we all 
become better acquainted and begin working 
together,” said Dr. Adler. “In essence, the College  
is remaining the same, with renewed prospects for 
a wonderful future.”
He commented on the goodwill and positive atmos-
phere that have characterized months of preparation 
and collaboration involving many members of the 
College community. At a meeting between Dr. Kadish 
and the academic leadership on June 7, there was 
even more positive dialog. “The faculty is eager to  
interact with Dr. Kadish,” said Norman Levine, Ph.D., 
president of the Faculty Senate. “We are pleased 
with the focus on research development and fund-
raising, and are very interested in being involved in 
what is to come.”
Future campus meetings will address the financial 
resources that have been earmarked for the College, 
and will engage processes that will help determine 
how best to use these funds. 
“We are delighted to welcome the New York Medical 
College community into the Touro College and 
University family,” Dr. Kadish summed up. “We are 
committed to working together to maximize our 
collective potential as we pursue excellence in the 
teaching of medicine, the biomedical sciences and 
healthcare education.”
At the May 25 press event in Bryant Park, Karl P. Adler, M.D., 
chief executive officer, and Alan Kadish, M.D., president, posed 
before a statue of William Cullen Bryant with a framed copy of 
the New York Medical College charter.
“ We are pleased with the focus on 
research development and fundraising, 
and are very interested in being 
involved in what is to come.”
Watch the video of the May 25 press conference  
at www.nymc.edu/nymc-touro or scan QR code to watch 
on your smart phone!
Norman Levine, Ph.D.
President, Faculty Senate
For further information:  
New York Medical College
Office of Public Relations
40 Sunshine Cottage Road




43 West 23rd Street
New York, N.Y. 10010
(212) 463-0400 x5530
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Touro* at a Glance 
•  Touro College is America’s largest not-for-profit independent  
institution of higher and professional education under Jewish  
auspices. 
•  Chartered: 1970
•  Enrollment: Approximately 19,000 students studying at 32 loca-
tions, mostly in New York but also in California, Florida, Nevada, 
Moscow, Israel, Berlin and Paris. Students are pursuing graduate 
and professional degrees in such fields as medicine, law, busi-
ness, education, and Jewish studies, among other areas.
•  Faculty: Total: 4,930—Full Time: 2,091—Part Time: 1,317—
Voluntary/Clinical: 1,522
•  Alumni: Approximately 74,561
•  Operating Budget: $410 million
•  Degrees and Programs of Study: 
Doctoral: Ph.D. 
Professional: D.N.P., D.O., DPT, Dr. PH, J.D., M.D., PharmD  
Master’s: LL.M, M.A., M.B.A., M.P.H., M.P.S., M.S., M.S.W. 
Bachelor’s: B.A., B.P.A., B.S. 
Associate: A.A., A.A.S., A.O.S., A.S.
•  Certificates: Various certificate degree programs offered at  
graduate and undergraduate levels, in such areas as bilingual 
education, school leadership, business and digital media arts.
*Includes Touro College, Touro University, and New York Medical College
New York Medical College
A Member of the Touro College and University System
